TAP Caucus


Point of View: Should Patients Over 70 Receive Aggressive Therapy for Acute Myeloid Leukemia?

Charles A. Schiffer, MD, and Farhad Ravandi, MD  / August 15, 2011

Despite Advances, Little Overall Improvement Seen in Treatment of Older Adults with AMLBy Charles A. Schiffer, MD The outcome of treatment of older adults with acute myeloid leukemia (AML) remains unsatisfactory, although certainly not a totally futile exercise. Patients satisfying the entry criter...




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.